Rgenta Therapeutics
PrivateLast Round
Series A
Nov 29, 2022
Total Funding Raised
$90M
Company Overview
Rgenta Therapeutics is a biotechnology company that develops oral, small-molecule RNA-targeting medicines for oncology and neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rgenta Therapeutics Comparables
Compare Rgenta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remix Therapeutics | 88% | |
| Arrakis Therapeutics | 86% | |
| Accent Therapeutics | 84% | |
Rgenta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 29, 2022 | ||||
| Seed | May 25, 2021 | ||||
| Seed | Apr 2, 2020 |
Rgenta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series A, Seed |
| Legend Star | Seed |
| Korea Investment Partners | Series A |
| Kaitai Capital | Seed, Series A |
| MPC | Series A, Seed |
| Boehringer Ingelheim Venture Fund | Series A, Seed |
| Lilly Asia Ventures | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Phase 1a/b study data released for oral MYB splicing modulator RGT-61159.
- Apr 21, 2026
Abstract accepted for poster presentation at the 2026 ASCO Annual Meeting.
Rgenta Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rgenta Therapeutics's valuation, stock price, and market status.